| Cardiac autonomic neuropathy in type 1 and type 2 diabetes patients A Moţăţăianu, S Maier, Z Bajko, S Voidazan, R Bălaşa, A Stoian BMC neurology 18, 1-9, 2018 | 60 | 2018 |
| Predicting functional outcome of ischemic stroke patients in Romania based on plasma CRP, sTNFR-1, D-Dimers, NGAL and NSE measured using a biochip array A Huţanu, M Iancu, R Bălaşa, S Maier, M Dobreanu Acta pharmacologica sinica 39 (7), 1228-1236, 2018 | 46 | 2018 |
| Autoimmune encephalitis in COVID-19 infection: our experience and systematic review of the literature A Stoian, M Stoian, Z Bajko, S Maier, S Andone, RA Cioflinc, A Motataianu, ... Biomedicines 10 (4), 774, 2022 | 32 | 2022 |
| The impact of CYP2C19 loss-of-function polymorphisms, clinical, and demographic variables on platelet response to clopidogrel evaluated using impedance aggregometry A Mărginean, C Bănescu, V Moldovan, A Scridon, M Mărginean, R Bălaşa, ... Clinical and Applied Thrombosis/Hemostasis 23 (3), 255-265, 2017 | 25 | 2017 |
| Depression in multiple sclerosis-review S Maier, R Balasa, M Buruian, A Maier, Z Bajko Romanian Journal of Neurology 14 (1), 22-29, 2015 | 25 | 2015 |
| Common carotid artery occlusion: a case series Z Bajkó, R Bălaşa, A Moţăţăianu, S Maier, OC Chebuţ, S Szatmári International Scholarly Research Notices 2013, 2013 | 25 | 2013 |
| Natalizumab changes the peripheral profile of the Th17 panel in MS patients: new mechanisms of action RI Balasa, M Simu, S Voidazan, LI Barcutean, Z Bajko, A Hutanu, I Simu, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2017 | 24 | 2017 |
| Assessment of interleukin-17A, interleukin-10 and transforming growth factor-beta1 serum titers in relapsing remitting multiple sclerosis patients treated with avonex, possible … R Balasa, S Maier, S Voidazan, A Hutanu, Z Bajko, A Motataianu, B Tilea, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2017 | 20 | 2017 |
| Stroke secondary to giant‑cell arteritis: A literature review Z Bajko, R Balasa, S Maier, A Motataianu, L Barcutean, S Andone, ... Experimental and Therapeutic Medicine 22 (2), 1-7, 2021 | 18 | 2021 |
| Plasma biomarkers as potential predictors of functional dependence in daily life activities after ischemic stroke: A single center study A Hu, M Iancu, S Maier, R Bălaşa, M Dobreanu Annals of Indian Academy of Neurology 23 (4), 496-503, 2020 | 16 | 2020 |
| The matrix metalloproteinases panel in multiple sclerosis patients treated with natalizumab: a possible answer to natalizumab non-responders R Balasa, C Bianca, V Septimiu, S Iunius, H Adina, A Sebastian, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2018 | 16 | 2018 |
| Clinical and serological biomarkers of treatment's response in multiple sclerosis patients treated continuously with interferonβ-1b for more than a decade LI Bărcuţean, A Romaniuc, S Maier, Z Bajko, A Moţăţăianu, H Adina, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2018 | 15 | 2018 |
| Malignant middle cerebral artery infarction secondary to traumatic bilateral internal carotid artery dissection. A case report Z Bajkó, R Bălaşa, A Moţăţăianu, L Bărcuţean, A Stoian, N Stirbu, S Maier The Journal of Critical Care Medicine 2 (3), 135-141, 2016 | 15 | 2016 |
| High‑dose intravenous immunoglobulins as a therapeutic option in critical illness polyneuropathy accompanying SARS‑CoV‑2 infection: A case‑based review of the literature A Stoian, Z Bajko, S Maier, RA Cioflinc, BL Grigorescu, A Moțățăianu, ... Experimental and Therapeutic Medicine 22 (4), 1-11, 2021 | 13 | 2021 |
| Pontine cavernoma haemorrhage at 24 weeks of pregnancy that resulted in eight-and-a-half syndrome S Maier, A Motataianu, Z Bajko, A Romaniuc, A Balasa Acta Neurologica Belgica 119, 471-474, 2019 | 13 | 2019 |
| Stroke secondary to traumatic carotid artery injury–a case report Z Bajkó, S Maier, A Moțățăianu, R Bălașa, S Vasiu, A Stoian, S Andone The Journal of Critical Care Medicine 4 (1), 23-28, 2018 | 13 | 2018 |
| The determinants of depression in a Romanian cohort of multiple sclerosis patients S Maier, M Buruian, A Maier, A Moţăţăianu, S Voidăzan, Z Bajkó, ... Acta Neurologica Belgica 116, 135-143, 2016 | 13 | 2016 |
| Gender differences in risk factor profile and clinical characteristics in 89 consecutive cases of cerebral venous thrombosis Z Bajko, A Motataianu, A Stoian, L Barcutean, S Andone, S Maier, ... Journal of Clinical Medicine 10 (7), 1382, 2021 | 12 | 2021 |
| INTERFERON-β 1A, AN IMMUNOMODULATOR IN RELAPSING REMITTING MULTIPLE SCLEROSIS PATIENTS. THE EFFECT ON PRO-INFLAMMATORY CYTOKINES. S Maier, A Motataianu, L Barcutean, A Balint, A Hutanu, B Zoltan, A Stoian, ... Farmacia 68 (1), 2020 | 12 | 2020 |
| UNDERSTANDING THE MECHANISM OF ACTION OF INTRAVENOUS IMMUNOGLOBULINS: A TEN YEARS EXPERIENCE IN TREATING GUILLAIN BARRÉ SYNDROME. A Stoian, A Motataianu, L Barcutean, S Maier, Z Bajko, S Voidazan, ... Farmacia 68 (3), 2020 | 10 | 2020 |
